Two Sigma Advisers’s Benitec Biopharma BNTC Stock Holding History

Two Sigma Advisers’s Portfolio BNTC Stock Details BNTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,365	Closed	-$3.94K	–	2597
2022 Q4	$3.94K	Buy	+1,365	New	+$4.62K	﹤0.01%	2481
2021 Q2	–	Sell	-694	Closed	-$61K	–	2461
2021 Q1	$61K	Sell	694 -3,203	-82%	-$218K	﹤0.01%	2487
2020 Q4	$199K	Buy	+3,897	New	+$194K	﹤0.01%	2174

Other funds holding BNTC

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Two Sigma Advisers's BNTC Position: Q1 2023 in Review

Two Sigma Advisers sold out of Benitec Biopharma (BNTC) in Q1 2023, closing a stake of 1,365 shares — an estimated $3.94K sold.

Two Sigma Advisers first reported a position in BNTC in Q4 2020 and held it in 3 quarters. The position peaked at $199K in Q4 2020. 21 funds tracked by Wall St. Rank hold BNTC as of Q1 2023.

Two Sigma Advisers reported no remaining Benitec Biopharma position as of Q1 2023 after selling out during the quarter.
Two Sigma Advisers sold 1,365 Benitec Biopharma shares in Q1 2023, an estimated $3.94K.
Two Sigma Advisers first reported a position in Benitec Biopharma in Q4 2020 and held it in 3 quarters.
Two Sigma Advisers's Benitec Biopharma position peaked at $199K in Q4 2020.
21 funds tracked by Wall St. Rank held Benitec Biopharma as of Q1 2023.

Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.